Hounsfield unit value and clot length in the acutely occluded vessel and time required to achieve thrombectomy, complications and outcome

Journal of NeuroInterventional Surgery

Volumn 6, Issue 6, 2014, Pages 423-427

  Spiotta, Alejandro M ^a   Vargas, Jan ^a   Hawk, Harris ^a   Turner, Raymond ^a   Chaudry, M Imran ^a   Battenhouse, Holly ^a   Turk, Aquilla S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CLOTTING LENGTH; BLOOD CLOTTING PARAMETERS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOUNSFIELD UNIT SCALE; HUMAN; MAJOR CLINICAL STUDY; MECHANICAL THROMBECTOMY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPERATION DURATION; PATHOLOGICAL ANATOMY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADULT; ARTERIAL OCCLUSIVE DISEASES; BRAIN ARTERY; COMPUTER ASSISTED TOMOGRAPHY; FACTUAL DATABASE; FEMALE; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RADIOGRAPHY; THROMBECTOMY;

ADULT; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL ARTERIES; DATABASES, FACTUAL; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBECTOMY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84904575778     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010765     Document Type: Article

References (22)

1. Chimowitz MI. Endovascular treatment for acute ischemic stroke-still unproven. N Engl J Med 2013;368:952-5.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
3. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
4. Sandercock P, Lindley R, Wardlaw J, et al. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials 2011;12:252.
5. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82. (Pubitemid 44897621)
6. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
7. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
8. Bose A, Henkes H, Alfke K, et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13.
9. Flint AC, Duckwiler GR, Budzik RF, et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274-80. (Pubitemid 351664267)
10. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848-54.
11. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
12. Turk AS, Magarick JA, Frei D, et al. CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointerv Surg. Published Online First: 26 Nov 2012. doi:10.1136/neurintsurg-2011-010067
13. Schuierer G, Huk W. The unilateral hyperdense middle cerebral artery: an early CT-sign of embolism or thrombosis. Neuroradiology 1988;30:120-2.
14. Kharitonova T, Ahmed N, Thoren M, et al. Hyperdense middle cerebral artery sign on admission CT scan-prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009;27:51-9.
15. Launes J, Ketonen L. Dense middle cerebral artery sign: an indicator of poor outcome in middle cerebral artery area infarction. J Neurol Neurosurg Psychiatry 1987;50:1550-2. (Pubitemid 17156460)
16. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17:79-85. (Pubitemid 26024712)
17. Puig J, Pedraza S, Demchuk A, et al . Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2012;33:90-6.
18. Yoo AJ, Frei D, Tateshima S, et al. The Penumbra Stroke System: a technical review. J Neurointervent Surg 2012;4:199-205.
19. Agarwal P, Kumar S, Hariharan S, et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis 2004;17:182-90. (Pubitemid 38529196)
20. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-83. (Pubitemid 351619459)
21. Moftakhar P, English JD, Cooke DL, et al. Density of thrombus on admission CT predicts revascularization efficacy in large vessel occlusion acute ischemic stroke. Stroke 2013;44:243-5.
22. Koo CK, Teasdale E, Muir KW. What constitutes a true hyperdense middle cerebral artery sign? Cerebrovasc Dis 2000;10:419-23.